Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to -$2.4 million.

  • Journey Medical's Free Cash Flow fell 10596.37% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.9 million, marking a year-over-year increase of 8589.27%. This contributed to the annual value of -$24.1 million for FY2024, which is 1015291.67% down from last year.
  • As of Q3 2025, Journey Medical's Free Cash Flow stood at -$2.4 million, which was down 10596.37% from -$942000.0 recorded in Q2 2025.
  • In the past 5 years, Journey Medical's Free Cash Flow ranged from a high of $18.7 million in Q3 2023 and a low of -$19.1 million during Q1 2022
  • Its 5-year average for Free Cash Flow is -$2.7 million, with a median of -$3.2 million in 2021.
  • Its Free Cash Flow has fluctuated over the past 5 years, first tumbled by 150455.55% in 2022, then surged by 35744.3% in 2023.
  • Quarter analysis of 5 years shows Journey Medical's Free Cash Flow stood at -$3.2 million in 2021, then decreased by 19.65% to -$3.8 million in 2022, then plummeted by 330.66% to -$16.5 million in 2023, then soared by 113.47% to $2.2 million in 2024, then tumbled by 207.1% to -$2.4 million in 2025.
  • Its Free Cash Flow stands at -$2.4 million for Q3 2025, versus -$942000.0 for Q2 2025 and -$2.8 million for Q1 2025.